Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study
The Journal of Infection in Developing Countries · 28.02.2026 · 20 (02) · 160-166
DOI: 10.3855/jidc.21878 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 28.02.2026. Verfasst von Jehat Kiliç und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences, Gazi Yasargil Training and Research Hospital, Department of Internal Medicine, Diyarbakir, Turkey. Hauptthemen laut MEDLINE: COVID-19, Mean Platelet Volume, Erythrocyte Indices. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study investigates RDW and MPV as simple, cost-effective markers linked to increased mortality in COVID-19, highlighting their potential prognostic value in viral infections.
Methods
This retrospective observational study examined hospitalized COVID-19 patients from 2020 to 2022, assessing clinical outcomes such as ICU admission, hospital stay duration, and mortality. It focused on the prognostic value of Red Cell Distribution Width (RDW) and Mean Platelet Volume (MPV), investigating whether elevated levels of these markers could serve as accessible indicators of mortality risk.
Results
The mean age at diagnosis among patients was 48.07 ± 17.33 years. The mean hospital stay was 5.82 ± 5.44 days. Among 1,810 patients, elevated Red Cell Distribution Width (RDW > 15%) and Mean Platelet Volume (MPV > 11.5 fL) were associated with significantly higher mortality rates (p < 0.01 and p = 0.014, respectively). Logistic regression analysis identified age, male sex, length of hospital stay, WBC count, RDW-CV, glucose, ferritin, and low albumin as independent predictors of mortality. Conversely, MPV, D-dimer, creatinine, calcium, and ALT were not significant mortality predictors. These findings suggest that routine markers, particularly RDW and WBC, may serve as accessible and cost-effective tools for early risk stratification in COVID-19 patients, while others, like MPV, may have limited independent prognostic value in this context.
Conclusions
RDW and MPV, routinely available from blood tests, may help identify early clinical deterioration, supporting timely interventions to improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Health Sciences, Gazi Yasargil Training and Research Hospital, Department of Internal Medicine, Diyarbakir, Turkey .
Zitieren
APA
Kiliç, J., Alakuş, Ö. F., & Solmaz, İ. (2026). Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study. The Journal of Infection in Developing Countries, 20(02), 160-166. https://doi.org/10.3855/jidc.21878
Vancouver
Kiliç J, Alakuş ÖF, Solmaz İ. Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study. The Journal of Infection in Developing Countries. 2026;20(02):160-166. doi:10.3855/jidc.21878
BibTeX
@article{Kili2026,
author = {Kiliç, Jehat and Alakuş, Ömer F and Solmaz, İhsan},
title = {Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {02},
pages = {160--166},
doi = {10.3855/jidc.21878}
}
EUVIMED